Afleveringen
-
One of the most common clinical presentations to ophthalmologist is 'the eyelid lesion'. While sometimes it might seem obvious what the diagnosis is, other times it's tough to make a spot diagnosis or even to decipher whether the lesion is concerning or not. So what are some helpful examination tips to help us discern the benign from the malignant? Oculoplastics specialist Dr. Lisa Jagan joins the podcast to share an effective approach on how to decide what types of eyelid lesions warrant a biopsy.
This episode is sponsored by Sun Pharma Canada - https://sunpharma.com/canada/
Check out Lid Express to help expedite a patient's referral for an eyelid lesion - https://clarityeye.ca/services/lid-express/
Become a supporter of this podcast: https://www.spreaker.com/podcast/blind-spot-the-eye-doctor-s-podcast--5819306/support. -
Extended depth of focus (EDOF) lenses have transofmed the intraocular lens (IOL) landscape. As opposed to the binary choice of a monofocal or a multifocal IOL, there is an 'in-between' option that allows for more intermediate vision than monofocal lenses but less dysphotopsias than the mutifocal lenses. How do these lenses work, how should we explain them to patients, and what are the factors that guide our decisions on lens selection? Dr. Eric Donnenfeld joins the podcast.
This episode is sponsored by SunPharma Canada - https://sunpharma.com/canada/
Become a supporter of this podcast: https://www.spreaker.com/podcast/blind-spot-the-eye-doctor-s-podcast--5819306/support. -
Zijn er afleveringen die ontbreken?
-
Cataracts and AMD are two of the most common ocular pathologies. But in patients who have both conditions, are there special considerations that should be taken into account? Should cataract surgey potentially be delayed in AMD patients because a protective effect of the cataract? Does cataract surgery exacerbate AMD and potentially lead to progression to geographic atrophy or conversion to wet AMD? Dr. Ashkan Abbey joins the podcast.
This episode is sponsored by Sun Pharma Canada - https://sunpharma.com/canada/
Become a supporter of this podcast: https://www.spreaker.com/podcast/blind-spot-the-eye-doctor-s-podcast--5819306/support. -
Pterygium surgery is one of the more common procedures performed by ophthalmologists. Yet despite how common it is, multiple techniques are used by different doctors. In this episode, Dr. Allan Slomovic joins the podcast to share tips on pterygium removal, indications for excision, and pearls on recurrent pterygia.
Become a supporter of this podcast: https://www.spreaker.com/podcast/blind-spot-the-eye-doctor-s-podcast--5819306/support. -
July is Dry Eye Awareness month. In this episode, five cornea specialists each contribute a tip on how to better diagnose and manage dry eye. Speakers includ Dr. Clara Chan, Dr. Chris Rapuano, Dr. Ashley Brissette, Dr. Tanya Trinh, and host Dr. Zale Mednick.
This episode is sponsored by Sun Pharma Canada
Become a supporter of this podcast: https://www.spreaker.com/podcast/blind-spot-the-eye-doctor-s-podcast--5819306/support. -
While there are specific guidelines for diagnosis, not every patient falls easily into a particular category of glaucoma. Many times, it can be challenging to place some patients neatly into one of the glaucoma buckets. So what are some tips that can help us in diagnosing these grey cases that may or may not be glaucoma? And how does this impact treatment decisions? Are there certain cases in which it’s okay to monitor a patient and wait for glaucoma progression? Or should all patients suspected of having glaucoma be treated at the first visit? Dr. Irfan Kherani joins the podcast.
Become a supporter of this podcast: https://www.spreaker.com/podcast/blind-spot-the-eye-doctor-s-podcast--5819306/support. -
Recurrent Corneal Erosion Syndrome (RCES) is an extremely uncomfortable condition for patients to live with. With so many management options, including ointments, bandage contact lenses, superficial keratectomy, anterior stromal puncture, and PTK, what actually works best? Wills Eye Hospital Cornea Specialst Dr. Chris Rapuano joins the podcast.
This episode is sponsored by Sun Pharma Canada - https://sunpharma.com/canada/
Become a supporter of this podcast: https://www.spreaker.com/podcast/blind-spot-the-eye-doctor-s-podcast--5819306/support. -
The incidence of musculoskeletal injuries in ophthalmology is probably higher than you think. Whether it's an acute injury or a chronic injury from poor posture and positioning, ophthalmologists and optometrists are at high risk for long-term back pain and other musculoskeletal problems, due to the nature of our work. So how can we better at keeping ourselves healthy, both in the short-term and in the long-run? Dr. R. Rishi Gupta joins the podcast.
Become a supporter of this podcast: https://www.spreaker.com/podcast/blind-spot-the-eye-doctor-s-podcast--5819306/support. -
The toric intraocular lenses (IOL) is a mainstay in the treatment of astigmatism during cataract surgery. Many people have different thresholds, however, for when they would consider a toric IOL. What is the appropriate amount of astigmatism that warrants treatment with a toric lens? Does the threshold vary if a premium lens is being used? What lens implantation techniques can be implemented to achieve the best possible results with a toric lens?
This episode is sponsored by Sun Pharma Canada - https://sunpharma.com/canada/
Become a supporter of this podcast: https://www.spreaker.com/podcast/blind-spot-the-eye-doctor-s-podcast--5819306/support. -
LASIK has been the procedure of choice in refractive surgery for many years now. But over the last decade, the development of SMILE has changed the landscape in refractive surgery. Especially popular in Europe and China, many ophthalmologists are offering their patients SMILE in place of LASIK. So what exactly is SMILE, and why do many view it as a superior alternative to LASIK? Dr. Walter Sekundo, the developer of the SMILE procedure, joins the podcast.
Become a supporter of this podcast: https://www.spreaker.com/podcast/blind-spot-the-eye-doctor-s-podcast--5819306/support. -
As excitement grows regarding the upcoming solar eclipse, anxiety is also increasing amongst patients. How should we be counseling concerned patients regarding the solar eclipse and what precautions they should be taking to protect their eyes? Dr. Tina Felfeli joins the podcast.
Become a supporter of this podcast: https://www.spreaker.com/podcast/blind-spot-the-eye-doctor-s-podcast--5819306/support. -
Traditionally, most of us were taught that after cataract surgery, a patient should be assessed on day one, week one, and month one. But what are these recommendations based on? Practically speaking, does our typical survellance of post-operative cataract surgery patients make sense, or are we overly dogmatic in our approach? Dr. Uday Devgan, aka 'The Cataract Coach', joins the podcast.
Become a supporter of this podcast: https://www.spreaker.com/podcast/blind-spot-the-eye-doctor-s-podcast--5819306/support. -
The traditional paradigm is that when a patient presents with acute angle closure due to pupil block, a peripheral iridotomy (PI) must be performed immediately. But in reality, is this always the best approach? Is it safe to treat medically for a period of time before the PI? In which situations might a PI actually exacerbate the acute angle closure? Dr. Ike Ahmed joins the podcast.
Become a supporter of this podcast: https://www.spreaker.com/podcast/blind-spot-the-eye-doctor-s-podcast--5819306/support. -
We all know that keratoconus is very highly associated with eye rubbing. But in general, the widely held belief has been that keratoconus is just associated with eye rubbing, one of multiple factors that leads to the condition. But have we gotten it wrong? Is eye rubbing not merely associated with keratoconus, but actually the sole causative factor of keratoconus? Has there been a huge blind spot in our basic understanding of keratoconus development and progression? Dr. Damien Gatinel joins the podcast.
Become a supporter of this podcast: https://www.spreaker.com/podcast/blind-spot-the-eye-doctor-s-podcast--5819306/support. -
Acetazolamide is a common and important medication used in ophthalmology. It is used as a treatment for both high intraocular pressure and high intracranial pressure. Yet despite its many uses, many ophthalmologists feel nervous when prescribing it due its potential side effects and the concern of sulfa allergy. And while caution is always a good thing, have we perhaps overstated the risks with acetazolamide to such a point that we don’t use it enough? What exactly is sulfa allergy, and does it even apply to acetazolamide? And how dangerous is acetazolamide, and how should we be counseling patients when prescribing it? Dr. Deborah Friedman joins the podcast.
Learn more about Dr. Friedman at www.neuroeyes.com
Become a supporter of this podcast: https://www.spreaker.com/podcast/blind-spot-the-eye-doctor-s-podcast--5819306/support. -
A central retinal artery occlusion is arguably one of the worst ocular events that can occur, given its extremely poor visual prognosis. As such, our efforts to find an effective treatment for CRAO have been extensive, but in many regards, inadequate. There are certain treatment options that we all learn in residency to try and halt a CRAO, but for the most part, many of these techniques are fairly unproven and don’t work so well. So what does actually work? And is the evidence for TPA strong enough that we should be routinely recommending it in appropriate cases? Dr. Rishi Gupta joins the podcast.
Learn more about Dr. Gupta at https://rishiguptamd.com/about/
Learn more about Dr. Gupta's books at https://rishiguptamd.com/textbooks/
Become a supporter of this podcast: https://www.spreaker.com/podcast/blind-spot-the-eye-doctor-s-podcast--5819306/support. -
Over the past two decades, Botox and Fillers have changed the landscape of cosmetic plastic surgery, including the field of oculoplastics. But how exactly to Botox and Fillers work, and more importantly, how should patients be counseled on these elective treatments? And from a philosophical standpoint, has the world of cosmetic surgery gone too far in 'de-aging' the population and perhaps further stigmatizing the natural process of getting older? Oculoplastics specialist Dr. Harmeet Gill joins the podcast.
Become a supporter of this podcast: https://www.spreaker.com/podcast/blind-spot-the-eye-doctor-s-podcast--5819306/support. -
Blepharitis is a common diagnosis, but it’s also an umbrella term that encompasses many different clinical disorders which require varying treatment approaches. Many patients struggle with chronic blepharitis, where it’s tough to find an effective treatment. So what exactly is the best approach to blepharitis? How does one differentiate staph blepharitis from demodex? What are the most effective treatments on the market? And from a preventative standpoint, what exactly is lid hygiene, and is it something we should routinely be recommending to our patients? Dr. Ashley Brissette joins the podcast.
Check out Dr. Brissette's Eye Care Products
www.dailypractice.com
Follow Dr. Brissette on Social Media
Instagram @abrissettemd
TikTok @abrissettemd
Become a supporter of this podcast: https://www.spreaker.com/podcast/blind-spot-the-eye-doctor-s-podcast--5819306/support. -
Flashes and floaters is one of the most common presenting complaints to eye care professionals. And while most of us understand the general pathophysiology of the vitreous separating from the retina, some of the nuances may not be as clear. Why do flashes and floaters persist so differently in patients? Why do flashes and floaters continue even after a vitrectomy? How common are retinal tears when one experiences new symptoms? And how, ultimately, should this affect our guidelines for monitoring patients who have new flashes and floaters? Dr. Efrem Mandelcorn joins the podcast.
This episode is sponsored by Canadian Eye Care Today. Access the journal at https://canadianeyecaretoday.com
Become a supporter of this podcast: https://www.spreaker.com/podcast/blind-spot-the-eye-doctor-s-podcast--5819306/support. -
Viral conjunctivitis is one of the most common presentations to eye care professionals. It’s typically easy to diagnose, and traditionally, the treatment has simply been cool compresses and observation. But have we been too lax in our treatment of viral conjunctivitis? What, if any, are the roles of steroids, iodine, and antivirals in the treatment of this common condition? Dr. Francis Mah joins the podcast.
Become a supporter of this podcast: https://www.spreaker.com/podcast/blind-spot-the-eye-doctor-s-podcast--5819306/support. - Laat meer zien
